Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Home
Targeted Medical Pharma Inc
Targeted Medical Pharma Breaks Ground in the Consumer Goods Market
Published Dec 3 2015
3 min read

Targeted Medical Pharma Breaks Ground in the Consumer Goods Market

Targeted Medical Pharma, Inc. (OTCQB: TRGM), announced the establishment of a new subsidiary, Amino Nutritionals LLC, that will specialize in the development and marketing of THERALEVE™, a proprietary consumer product for chronic pain sufferers to be sold in the United States and abroad.

The Company is pleased to announce the hiring of Joshua Levine as the Vice President of Direct Consumer Sales. Mr. Levine will spearhead the direct marketing efforts for Amino Nutritionals, and will be responsible for building the infrastructure required for market development and growth of the new direct to consumer products. Josh was most recently the Vice President of Finance for Ideal Living Management, LLC.

“The Company has been through a challenging year, restructuring management and operations to improve profitability and shareholder value. Adding Josh to our corporate team signifies our commitment to growth,” said Kim Giffoni, CEO at Targeted Medical Pharma. “Our patented Targeted Cellular Technology that is responsible for the efficacy and safety of our medical foods will give THERALEVE™ a distinct advantage in the direct to consumer market.”

About Targeted Medical Pharma, Inc.
Targeted Medical Pharma, Inc. (OTCQB:TRGM) is a Los Angeles based biotechnology company that develops and manufactures amino acid based Medical Foods featuring the patented Targeted Cellular Technology. The Company distributes these products to physicians, pharmacies, hospitals and patients throughout the United States, to effectively treat pain, obesity, hypertension, sleep and cognitive disorders without the serious side effects associated with many drug therapies.